This inventor holds 2 USPTO granted patents. Top assignees: Dompé Farmaceutici S.p.a., Dimpe' Spa. Active years: 1995-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1995-1998
Title: The Innovative Contributions of Roberto Curti
Introduction
Roberto Curti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-allergic properties. With a total of 2 patents, Curti's work has had a meaningful impact on medical science.
Latest Patents
Curti's latest patents include "Salts of 2-(3-benzoylphenyl) propionic acid with organic bases" and "Pharmacologically active derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane." These patents describe the processes for preparing these compounds, as well as the pharmaceutical compositions that contain them as active ingredients. The compounds exhibit notable anti-allergic activity, showcasing Curti's commitment to addressing health challenges.
Career Highlights
Throughout his career, Curti has worked with prominent companies in the pharmaceutical industry, including Dompe' Farmaceutici S.p.a. and Dimpe' Spa. His experience in these organizations has allowed him to refine his expertise and contribute to innovative solutions in drug development.
Collaborations
Curti has collaborated with esteemed colleagues such as Marco Mantovanini and Enrico Bosone. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Roberto Curti's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science, particularly in the area of anti-allergic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile